Abstract
Objective
To assess the impact of diet on the occurrence of proximal reflux episodes at the multichannel intraluminal impedance-pH monitoring (MII-pH) in patients with laryngopharyngeal reflux (LPR).
Methods
Patients with LPR symptoms and findings were recruited from three European hospitals. The LPR diagnostic was confirmed through MII-pH and patients were benefited from gastrointestinal (GI) endoscopy. Regarding the types of reflux at the MII-pH (acid, nonacid, mixed), patients received a 3 month-therapy based on the association of alkaline, low-fat and high-protein diet, proton pump inhibitors, alginate or magaldrate. Reflux symptom score (RSS) and reflux sign assessment (RSA) were used to evaluate laryngeal and extra-laryngeal symptoms and findings from pretreatment to posttreatment. The Global Refluxogenic Score (GRES) was used to assess the refluxogenic potential of the diet of the patients at baseline and posttreatment. The relationship between GRES severity; the MII-pH findings; GI endoscopy; and the therapeutic response was explored through multiple linear regression.
Results
Eighty-five LPR patients were included. The mean GRES significantly improved from pretreatment (50.7 ± 23.8) to posttreatment (27.3 ± 23.2; P = 0.001). Similarly, RSS and RSA significantly improved from baseline to posttreatment. The baseline GRES was significantly associated with the occurrence of proximal reflux episodes at the MII-pH (P = 0.001). Trends were found regarding the association between GRES and the occurrence of esophagitis (P = 0.06) and between hiatal hernia and DeMeester score (P = 0.06). There was a significant and strong association between the concomitant respect of diet and medication and the improvement of RSS (P = 0.001).
Conclusion
The consumption of high-fat, low-protein, high-sugar, acid foods, and beverages is associated with a higher number of proximal reflux episodes at the MII-pH, according to the global refluxogenic score of LPR patients.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Laryngopharyngeal reflux (LPR) is an inflammatory condition of the upper aerodigestive tract tissues related to direct and indirect effects of gastroduodenal content reflux, which induces morphological changes in the upper aerodigestive tract [1]. Many etiopathological mechanisms of reflux have been identified, including diet [2,3,4]; anxiety [5]; and autonomic nerve dysfunction [6, 7]. A diet composed of acid, high-fat, low-protein foods, and acid, alcoholic or high-sugar beverages leads to gastroesophageal dysfunction, including transient relaxations of lower (LES) and upper (UES) esophageal sphincters, which increase both acid esophageal and laryngopharyngeal exposure [8, 9]. The authors interested in diet and behavioral changes have mainly studied the impact of an alkaline, low-fat and high-protein diet in patients with LPR symptoms, but not demonstrated LPR [3] or with recalcitrant symptoms to proton pump inhibitors (PPIs), corresponding to potential resistant patients [4, 10]. The realization of researches investigating the involvement of diet in the development of LPR was limited by the lack of clinical tool providing rigorous rating to the refluxogenic potential of diet. Recently, experts of the LPR Study Group of Young Otolaryngologists of the International Federation of Oto-rhino-laryngological societies (YO-IFOS) developed an European diet score assessing the refluxogenic potential of foods and beverages [11]. Based on the pH and the composition of foods and beverages, the Refluxogenic Diet Score (REDS) provides a classification of foods and beverages, allowing secondarily, the rating of the refluxogenic potential of dishes and the overall diet of patients [11].
The aim of this study is to investigate the relationship between the diet of LPR patients, the clinical findings, and the results of the multichannel intraluminal impedance-pH monitoring (MII-pH).
Material and methods
The local ethics committee approved the study (n°BE076201837630). Patients were invited to participate and the informed consent was obtained.
Subjects and setting
From January 2018 to June 2019, patients with LPR symptoms and findings were enrolled from three European hospitals (CHU Saint-Pierre and Cesar De Pape Hospital, Brussels, Belgium; Polyclinique Elsan de Poitiers, Poitiers, France). The recruitment of patients was prospectively made through similar inclusion and exclusion criteria by one otolaryngologist in Poitiers (FB) and several otolaryngologists in Brussels (JRL, MPT, MH, AR, DD).
The diagnostic was confirmed through positive MII-pH. Gastrointestinal (GI) endoscopy was performed in patients with gastroesophageal reflux disease (GERD) symptoms and in patients of age ≥ 60 years, regarding the reduced esophageal sensitivity [12]. To be included, patients had to have positive LPR diagnosis at the MII-pH. Patients were excluded if they presented with one of the following conditions: smoking, alcohol dependence, pregnancy, neurological or psychiatric illness, upper respiratory tract infection within the last month, current use of anti-reflux treatment (i.e., PPIs, antihistamine, alginate, and magaldrate), previous history of neck surgery or trauma, benign vocal fold lesions, malignancy, history of ear, nose, and throat radiotherapy, and active seasonal allergies or asthma.
Multichannel intraluminal impedance-pH monitoring
The characteristics of MII-pH device, placement, and analyses have been described in previous publications [13]. In summary, the MII-pH was composed of eight impedance segments and two pH electrodes (Versaflex Z®, Digitrapper pH-Z testing System, Medtronic, Europe). Six impedance segments were placed along the esophageal zones (Z1–Z6) and they were centered at 19, 17, 11, 9, 7, and 5 cm above the LES. Two additional impedance segments were placed 1 and 2 cm above the UES in the hypopharyngeal cavity. The pH electrodes were placed 2 cm above LES and 1–2 cm below UES, respectively. Proximal reflux event was defined as an episode that reached two impedance sensors in the hypopharynx. Acid reflux episode consisted of an episode with pH ≤ 4.0. Non-acid reflux episode consisted of an episode with pH > 4.0. The LPR diagnostic consisted of the occurrence of ≥ 1 proximal episode [14].
Treatment and clinical outcomes
The therapeutic algorithm was based on recent recommendations of the LPR Study Group of YO-IFOS [1]. Based on the characteristics of LPR at the MII-pH (acid, non-acid, or mixed LPR), patients were treated with a personalized treatment scheme, including diet, behavioral changes, and the use of PPIs (pantoprazole) ± alginate ± magaldrate for 3 months. The respect of medication intake was carefully assessed posttreatment through a structured anamnesis.
Symptoms and findings were assessed from pretreatment to posttreatment with Reflux Symptom Score and Reflux [13] Sign Assessment [15], respectively.
Diet evaluation
Global Refluxogenic Score (GRES) was used to assess the diet habits of the patients. GRES consists of a score which rates the refluxogenic potential of foods and beverages (REDS) [11] that are usually consumed by patients; western European foods and beverages being classified into five categories from very low refluxogenic food/beverage (cat.1) to very high refluxogenic food/beverage (cat.5) (Tables 1, 2). In practice, based on Tables 1 and 2, the patient selects the foods and beverages that she/he have consumed over the previous 3 weeks and the physician may add the categories of the foods and beverages to get a score. In case of daily consumption of a food, the physician has to multiply the category of the food by the number of day on which it was consumed. Thus, at most the patient eats high refluxogenic foods/beverages, at the most the GRES will be high. At the end of the initial consultation, patient received a personalized diet grid identifying the foods and beverages to avoid.
The respect of the anti-reflux diet has been assessed posttreatment for evaluating the potential impact of diet on the clinical improvement.
Statistical methods
Statistical analyses were performed using the Statistical Package for the Social Sciences for Windows (SPSS version 22.0; IBM Corp, Armonk, NY, USA). The relationship between GRES and the MII-pH data and the impact of the respect of diet and medication on the clinical evolution were investigated through multiple linear regression. Changes in RSS, RSA, and GRES from pretreatment to posttreatment were evaluated using the Wilcoxon signed-rank test. A level of significance of P < 0.05 was used.
Results
From the 89 patients who were recruited, 85 completed the study. The characteristics of patients are described in Table 3. Globus sensation, chronic cough, throat pain, and sticky mucus were the main reasons for consultation. There were 36 acid, 31 mixed, and 18 non-acid LPRs. Forty (47%) patients had both LPR and GERD. The most common findings reported by the GI endoscopy were LES insufficiency (58.7%); esophagitis (42.9%); gastritis (42.9%); and hiatal hernia (33.3%). GI endoscopy was normal in 14.4% of cases. The mean value of GRES significantly decreased throughout the treatment (Table 3).
Clinical evolution
The RSS significantly decreased from pretreatment to posttreatment (Table 4). Precisely, the pretreatment to posttreatment improvements of RSS subscores were significant for ear, nose, and throat and digestive symptoms. The quality of life scores of RSS significantly decreased throughout treatment.
The RSA total score significantly decreased from pretreatment to posttreatment. Similar evolution was found for the RSA subscores (Table 5).
Association between GRES and clinical findings
Irrespective to the types of reflux (acid, non-acid, mixed), there was a significant positive association between GRES and the occurrence of proximal reflux episodes at the MII-pH (P = 0.001). This significant association was maintained considering the position of patient during the occurrence of reflux episodes [upright/daytime (P = 0.001) and recumbent/nighttime (P = 0.04)].
Trends were found regarding the association between GRES and the occurrence of esophagitis (P = 0.06); and hiatal hernia and DeMeester score (P = 0.06). Posttreatment, patients with higher GRES had higher score of indigestion (P = 0.003).
The respect of diet was not associated with better clinical improvement, when the variable (diet respect) was considered individually. Similar result was found for medication respect. However, there was a significant and strong association between the concomitant respect of diet and medication, and the improvement of RSS (P = 0.001). At most the patient respected the diet advices and the medication intake, at most the improvement of RSS was high.
Discussion
The role of diet in the development of reflux has long been recognized and well-studied in patients with GERD. In LPR, there are only a few conducted studies; all of them investigating the impact of low-fat, high-protein, and alkaline diet on the clinical evolution of LPR patients treated by PPIs or with recalcitrant symptoms [2, 3, 10, 16,17,18,19,20]. Nowadays, there is no study that specifically investigates the refluxogenic potential of foods and beverages on the development of LPR, regarding MII-pH. The main finding of this study is the strong association between the severity of the global refluxogenic diet score of the patient (GRES) and the occurrence of proximal reflux episodes at the MII-pH. In other words, at most the patients have high refluxogenic diet score, at most they have a high number of proximal reflux episodes; the refluxogenic diet, including acidic, high-fat and low-protein foods, spicy, high-fiber raw vegetables, and acidic, sparkling or alcoholic beverages. Many pathophysiological explanations may explain our results.
First, the digestion of fat or fried foods is longer than the digestion of low-fat foods. The increased emptying gastric time is associated with a high number of transient relaxations of LES, related increase of the esophageal acid exposure [21,22,23] and should be associated with UES relaxations regarding our results. Thus, there would be a positive association between the consumption of fat foods and development of esophagitis [24, 25]. Second, the LES pressure may also be decreased by high-osmolality beverages, coffee (caffeine), and some teas [26]; the latter being associated with an increase of erosive esophagitis [27]. Similar findings were partly reported for alcoholic beverages, including wine, beer, and liquor [27,28,29,30,31]. Alcoholic beverages would be associated with a decrease of the gastric pH (through gastrin stimulation) and a reduction of the perception of the esophageal acid reflux events [25, 32]. A moderate consumption of alcohol is even associated with a decrease of esophageal pH in asymptomatic individuals, regarding pH measurements [33,34,35,36]. A third class of foods reporting increased risk of reflux is the raw high-fiber vegetables and acidic fruits. The raw high-fiber vegetables are little digestible, which is associated with an increased gastric emptying time, whereas the fiber concentration is partly reduced once the vegetables are cooked [37]. Another factor is the acid content of some fruits and vegetables. In that respect, the tomato-derived products are high-refluxogenic foods, because they contain two prominent organic acids (citric and malic acids), which are the most potent triggers of acid reflux in prone individuals and higher tomato consumers [30, 38, 39]. Other mechanisms of the refluxogenic potential of fruits and vegetables are still unknown according to studies exhibiting that some fruits are associated with the increase of heartburn [40, 41] and GERD [42], irrespective of the fiber concentration or the pH [43]. Finally, as found in some studies [44,45,46], chilli and spicy foods are important factors negatively impacting the esophageal sphincter pressure, even if they do not change the esophageal motility [47,48,49].
However, these explanations could be balanced by some studies, which did not find significant impact of fat foods [50, 51], coffee (caffeine) or tea [52, 53], and alcohol [54,55,56] on LES tonicity, esophageal motility, or GERD development. In fact, the majority of these researches studied very specific food/beverage components and did not consider the global diet of patients. The focus on one specific food/beverage component may easily lead to controversial results, because there are many inter-individual factors involving in the digestive response to a food/beverage component. The inter-individual variability includes the component metabolism; the various trigger threshold of symptoms (mucosa perception); heredity; and many unknown environmental factors [11]. Thus, it has been demonstrated that the sensitivity of esophageal mucosa to acidic foods varies from one patient to another and would depend on the composition of food [25]. In that respect, the reduction of the perception of esophageal acid reflux events could be an important factor, leading to heterogeneity in the studies investigating the impact of a component of food/beverage in a cohort of patients considered as homogeneous. The metabolism of some refluxogenic molecules would be different from one patient to another [57, 58], leading to similar biases. For these reasons, the assessment of the global refluxogenic score of the patient needs to remain global, considering all refluxogenic diet factors.
Additionally to the composition, the pH of foods and beverages would be an important etiological factor of LPR with regard to studies reporting a significant clinical impact of alkaline water [2,3,4]. As expected, at most the food is acidic, at most the gastric content is acid, and the related gaseous droplets of reflux episodes that contain pepsin. Together, all high refluxogenic foods and beverages (the majority being classified in the category 5 regarding REDS) lead to a higher score of GRES and an obvious higher number of proximal reflux episodes. Because the MII-pH proximal sensors are placed in the hypopharynx, we may suspect that the consumption of the refluxogenic foods and beverages leads to UES relaxations.
The literature investigating the impact of diet in the development of UES abnormalities and the related-LPR symptoms remain lacking; limiting the comparison of our results with the literature. In fact, the lack of study assessing the impact of foods and beverages on LPR through MII-pH is related to two main points: the low use of MII-pH by otolaryngologists and the lack of development of score(s) that objectively rate(s) the refluxogenic potential of diet.
However, LPR is characterized by different mechanisms from GERD, i.e. daytime and upright gaseous reflux episodes (LPR) versus recumbent and liquid episodes (GERD), and the low prevalence of obese patients in LPR cohorts; involving different mechanisms of action of refluxogenic components of diet. These potential differences between GERD and LPR need to be explored in future studies, which should include a control group. The lack of control group is the main weakness of the present study, but it is difficult to realize MII-pH, especially in healthy individuals, regarding the cost of the technique and the inconveniences associated with the probe and device.
Conclusion
The diet of the LPR patients has a significant impact on the occurrence of proximal reflux episodes, which define the LPR diagnosis. The consumption of acid, high-fat and low-protein foods and acid, high-sugar or alcoholic beverages may also lead to higher risk of esophagitis, but this trend needs to be confirmed in larger cohorts. Future controlled studies are needed to better understand the pathophysiological mechanisms underlying the impact of diet in the development of LPR. These studies should consider the use of diet scores, MII-pH, and esophageal manometry to provide objective information for the study of the relationship between LPR and diet. Meanwhile, the food and beverage tables related to the Refluxogenic Diet Score and the Global Refluxogenic Score may be used for the management of LPR.
References:s
Lechien JR, Akst LM, Hamdan AL et al (2019) Evaluation and management of laryngopharyngeal reflux disease: state of the art review. Otolaryngol Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 160(5):762–782. https://doi.org/10.1177/0194599819827488
Zalvan CH, Hu S, Greenberg B, Geliebter J (2017) A comparison of alkaline water and mediterranean diet vs proton pump inhibition for treatment of laryngopharyngeal reflux. JAMA Otolaryngol Neck Surg 143(10):1023. https://doi.org/10.1001/jamaoto.2017.1454
Lechien JR, Huet K, Khalife M et al (2019) Alkaline, protein, low-fat and low-acid diet in laryngopharyngeal reflux disease: our experience on 65 patients. Clin Otolaryngol Off J ENT-UK Off J Neth Soc Oto-Rhino-Laryngol Cervico-Facial Surg 44(3):379–384. https://doi.org/10.1111/coa.13269
Koufman JA, Johnston N (2012) Potential benefits of pH 8.8 alkaline drinking water as an adjunct in the treatment of reflux disease. Ann Otol Rhinol Laryngol 121(7):431–434. https://doi.org/10.1177/000348941212100702
Joo Y-H, Song Y-S, Pae C-U (2017) Relationship between depression and laryngopharyngeal reflux. Psychiatry Investig 14(2):226–229. https://doi.org/10.4306/pi.2017.14.2.226
Wang AM, Wang G, Huang N et al (2019) Association between laryngopharyngeal reflux disease and autonomic nerve dysfunction. Eur Arch Oto-Rhino-Laryngol 276(8):2283–2287. https://doi.org/10.1007/s00405-019-05482-w
Lechien JR, Nandhan Sampath Kumar R, Chiesa-Estomba CM (2019) Laryngopharyngeal reflux and autonomic nerve dysfunction: What about stress? Eur Arch Oto-Rhino-Laryngol. https://doi.org/10.1007/s00405-019-05567-6
Ding H, Duan Z, Yang D et al (2017) High-resolution manometry in patients with and without globus pharyngeus and/or symptoms of laryngopharyngeal reflux. BMC Gastroenterol 17(1):109. https://doi.org/10.1186/s12876-017-0666-x
Passaretti S, Mazzoleni G, Vailati C, Testoni PA (2016) Oropharyngeal acid reflux and motility abnormalities of the proximal esophagus. World J Gastroenterol 22(40):8991–8998. https://doi.org/10.3748/wjg.v22.i40.8991
Koufman JA (2011) Low-acid diet for recalcitrant laryngopharyngeal reflux: therapeutic benefits and their implications. Ann Otol Rhinol Laryngol 120(5):281–287. https://doi.org/10.1177/000348941112000501
Lechien JR, Bobin F, Mouawad F et al (2019) Development of scores assessing the refluxogenic potential of diet of patients with laryngopharyngeal reflux. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-019-05631-1
Lechien JR, Finck C, Huet K et al (2017) Impact of age on laryngopharyngeal reflux disease presentation: a multi-center prospective study. Eur Arch Oto-Rhino-Laryngol 274(10):3687–3696. https://doi.org/10.1007/s00405-017-4671-z
Lechien JR, Bobin F, Muls V et al (2019) Validity and reliability of the reflux symptom score. Laryngoscope. https://doi.org/10.1002/lary.28017
Hoppo T, Komatsu Y, Nieponice A, Schrenker J, Jobe BA (2012) toward an improved understanding of isolated upright reflux: positional effects on the lower esophageal sphincter in patients with symptoms of gastroesophageal reflux. World J Surg 36(7):1623–1631. https://doi.org/10.1007/s00268-012-1537-9
Lechien JR, Rodriguez A, Dequanter D, Bobin F, Mouawad F, Muls V, Huet K, Harmegnies B, Remacle S, Finck C, Saussez S (2019) Validity and reliability of the reflux sign assessment (RSA). Ann Otol Rhinol Laryngol
Yang J, Dehom S, Sanders S, Murry T, Krishna P, Crawley BK (2018) Treating laryngopharyngeal reflux: evaluation of an anti-reflux program with comparison to medications. Am J Otolaryngol 39(1):50–55. https://doi.org/10.1016/j.amjoto.2017.10.014
Siupsinskiene N, Adamonis K (2003) Diagnostic test with omeprazole in patients with posterior laryngitis. Med Kaunas Lith 39(1):47–55
Chappity P, Kumar R, Deka RC, Chokkalingam V, Saraya A, Sikka K (2014) Proton pump inhibitors versus solitary lifestyle modification in management of laryngopharyngeal reflux and evaluating who is at risk: scenario in a developing country. Clin Med Insights Ear Nose Throat 7:1–5. https://doi.org/10.4137/CMENT.S13799
Nanda MS (2016) Role of adjuvant lifestyle modifications in patients with laryngopharyngeal reflux disease in hilly. Int J Sci Study 3(10):6
Giacchi RJ, Sullivan D, Rothstein SG (2000) Compliance with anti-reflux therapy in patients with otolaryngologic manifestations of gastroesophageal reflux disease. Laryngoscope 110(1):19–22. https://doi.org/10.1097/00005537-200001000-00004
Becker DJ, Sinclair J, Castell DO, Wu WC (1989) A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol 84(7):782–786
Nebel OT, Castell DO (1972) Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology 63(5):778–783
Sutphen JL, Dillard VL (1989) Dietary caloric density and osmolality influence gastroesophageal reflux in infants. Gastroenterology 97(3):601–604. https://doi.org/10.5555/uri:pii:0016508589906306
El-Serag HB, Satia JA, Rabeneck L (2005) Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 54(1):11–17. https://doi.org/10.1136/gut.2004.040337
Shapiro M, Green C, Bautista JM et al (2007) Assessment of dietary nutrients that influence perception of intra-oesophageal acid reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 25(1):93–101. https://doi.org/10.1111/j.1365-2036.2006.03170.x
Hamoui N, Lord RV, Hagen JA, Theisen J, Demeester TR, Crookes PF (2006) Response of the lower esophageal sphincter to gastric distention by carbonated beverages. J Gastrointest Surg Off J Soc Surg Aliment Tract 10(6):870–877. https://doi.org/10.1016/j.gassur.2005.11.010
Chang C-H, Wu C-P, Wang J-D et al (2017) Alcohol and tea consumption are associated with asymptomatic erosive esophagitis in Taiwanese men. PLoS ONE 12(3):e0173230. https://doi.org/10.1371/journal.pone.0173230
Niu C-Y, Zhou Y-L, Yan R et al (2012) Incidence of gastroesophageal reflux disease in Uygur and Han Chinese adults in Urumqi. World J Gastroenterol 18(48):7333–7340. https://doi.org/10.3748/wjg.v18.i48.7333
Mohammed I, Nightingale P, Trudgill NJ (2005) Risk factors for gastro-oesophageal reflux disease symptoms: a community study. Aliment Pharmacol Ther 21(7):821–827. https://doi.org/10.1111/j.1365-2036.2005.02426.x
Wang J-H, Luo J-Y, Dong L, Gong J, Tong M (2004) Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi’an of Northwest China. World J Gastroenterol 10(11):1647–1651. https://doi.org/10.3748/wjg.v10.i11.1647
O’Leary C, McCarthy J, Humphries M, Shanahan F, Quigley E (2003) The prophylactic use of a proton pump inhibitor before food and alcohol. Aliment Pharmacol Ther 17(5):683–686
Bujanda L (2000) The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol 95(12):3374–3382. https://doi.org/10.1111/j.1572-0241.2000.03347.x
Kaufman SE, Kaye MD (1978) Induction of gastro-oesophageal reflux by alcohol. Gut 19(4):336–338. https://doi.org/10.1136/gut.19.4.336
Vitale GC, Cheadle WG, Patel B, Sadek SA, Michel ME, Cuschieri A (1987) The effect of alcohol on nocturnal gastroesophageal reflux. JAMA 258(15):2077–2079
Rubinstein E, Hauge C, Sommer P, Mortensen T (1993) Oesophageal and gastric potential difference and pH in healthy volunteers following intake of coca-cola, red wine, and alcohol. Pharmacol Toxicol 72(1):61–65
Grande L, Manterola C, Ros E, Lacima G, Pera C (1997) Effects of red wine on 24-hour esophageal pH and pressures in healthy volunteers. Dig Dis Sci 42(6):1189–1193. https://doi.org/10.1023/a:1018893721735
Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J (2004) Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 53(12):1730–1735. https://doi.org/10.1136/gut.2004.043265
Richter JE (2000) Gastroesophageal reflux disease in the older patient: presentation, treatment, and complications. Am J Gastroenterol 95(2):368–373. https://doi.org/10.1111/j.1572-0241.2000.t01-1-01791.x
de Bortoli N, Guidi G, Martinucci I et al (2016) Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study. Dis Esophagus 29(2):197–204. https://doi.org/10.1111/dote.12319
López-Colombo A, Pacio-Quiterio MS, Jesús-Mejenes LY et al (2017) Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor. Rev Gastroenterol Mex 82(2):106–114. https://doi.org/10.1016/j.rgmx.2016.09.001
Feldman M, Barnett C (1995) Relationships between the acidity and osmolality of popular beverages and reported postprandial heartburn. Gastroenterology 108(1):125–131. https://doi.org/10.1016/0016-5085(95)90016-0
Eslami O, Shahraki M, Bahari A, Shahraki T (2017) Dietary habits and obesity indices in patients with gastro-esophageal reflux disease: a comparative cross-sectional study. BMC Gastroenterol 17(1):132. https://doi.org/10.1186/s12876-017-0699-1
Price SF, Smithson KW, Castell DO (1978) Food sensitivity in reflux esophagitis. Gastroenterology 75(2):240–243
Nebel OT, Fornes MF, Castell DO (1976) Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Am J Dig Dis 21(11):953–956
Allen ML, Mellow MH, Robinson MG, Orr WC (1990) The effect of raw onions on acid reflux and reflux symptoms. Am J Gastroenterol 85(4):377–380
Choe JW, Joo MK, Kim HJ et al (2017) Foods inducing typical gastroesophageal reflux disease symptoms in Korea. J Neurogastroenterol Motil 23(3):363–369. https://doi.org/10.5056/jnm16122
Yeoh KG, Ho KY, Guan R, Kang JY (1995) How does chili cause upper gastrointestinal symptoms? A correlation study with esophageal mucosal sensitivity and esophageal motility. J Clin Gastroenterol 21(2):87–90
Milke P, Diaz A, Valdovinos MA, Moran S (2006) Gastroesophageal reflux in healthy subjects induced by two different species of chilli (Capsicum annum). Dig Dis 24(1–2):184–188. https://doi.org/10.1159/000090323
Alsulobi AM, El-Fetoh NMA, Alenezi SGE et al (2017) Gastroesophageal reflux disease among population of Arar City, Northern Saudi Arabia. Electron Physician 9(10):5499–5505. https://doi.org/10.19082/5499
Colombo P, Mangano M, Bianchi PA, Penagini R (2002) Effect of calories and fat on postprandial gastro-oesophageal reflux. Scand J Gastroenterol 37(1):3–5
Pehl C, Waizenhoefer A, Wendl B, Schmidt T, Schepp W, Pfeiffer A (1999) Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal reflux in healthy subjects. Am J Gastroenterol 94(5):1192–1196. https://doi.org/10.1111/j.1572-0241.1999.01064.x
Boekema PJ, Samsom M, Smout AJ (1999) Effect of coffee on gastro-oesophageal reflux in patients with reflux disease and healthy controls. Eur J Gastroenterol Hepatol 11(11):1271–1276
Wei T-Y, Hsueh P-H, Wen S-H, Chen C-L, Wang C-C (2019) The role of tea and coffee in the development of gastroesophageal reflux disease. Ci Ji Yi Xue Za Zhi Tzu-Chi Med J 31(3):169–176. https://doi.org/10.4103/tcmj.tcmj_48_18
Rosaida MS, Goh K-L (2004) Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol 16(5):495–501
Stanghellini V (1999) Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 231:29–37
Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ (1994) Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut 35(5):619–624. https://doi.org/10.1136/gut.35.5.619
Pollock BG, Wylie M, Stack JA et al (1999) Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women. J Clin Pharmacol 39(9):936–940
Abernethy DR, Todd EL (1985) Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives. Eur J Clin Pharmacol 28(4):425–428
Acknowledgements
Vesale Grant and IRIS-Recherche Grant (Foundation Roi Baudouin).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Appendix 1:
The pH and the composition of lipids, carbohydrates, and proteins of the selected foods. The unit of the composition of food is g/100g. Some foods/beverages are characterized by the lack of components due their nature (water-pH; sugar; lipid) and, therefore, REDS is not available for these foods. C. Score score of composition of foods/beverages, L/P ratio lipid/protein ratio, REDS refluxogenic diet score. (XLSX 70 kb)
Rights and permissions
About this article
Cite this article
Lechien, J.R., Bobin, F., Muls, V. et al. Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring. Eur Arch Otorhinolaryngol 277, 511–520 (2020). https://doi.org/10.1007/s00405-019-05711-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-019-05711-2